BS, Biomolecular Science, University of Michigan
Clinical development of treatment resistance and lineage plasticity in CRPC
Email: oliviasw@umich.edu
Teacher who has altered my life: My pharmacology professor, Dr.Iñiguez-Lluhí, who emphasized the importance of learning above all. He taught me how biochemistry gives us an understanding of what areas to target when designing a drug or treatment plan.
In my time off, I enjoy: Soulcycle with friends, coffee shops, ice hockey, and FaceTiming various family members.
What major, other than your own, would you enjoy? If I didn’t pursue a Biomolecular Science major, I think I would like to pursue a Spanish major or minor and spend a semester abroad.
Kumaraswamy A, Duan Z, Flores D, Zhang C, Sehrawat A, Hu YM, Swaim OA, Rodansky E, Storck WK, Kuleape JA, Bedi K, Mannan R, Wang XM, Udager A, Ravikumar V, Bankhead A 3rd, Coleman I, Lee JK, Morrissey C, Nelson PS, Chinnaiyan AM, Rao A, Xia Z, Yates JA, & Alumkal JJ. LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function. JCI Insight (2023). DOI: 10.1172/jci.insight.167440